This newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents

Simple flat-rate database subscription plans Ultimate Plan Premium Plan Basic Plan One year $1,895 $1,695 $975 One month $475 $375 $275 48 hours $95 $75 Plan comparison    Site tour    Contact

Drug Patent Expirations for Feb 7 2012 Tradename Applicant Generic Name Patent Number Patent Expiration ALINIA Romark nitazoxanide 5,387,598 Feb 7, 2012 AZILECT Teva rasagiline mesylate 5,387,612 Feb 7, 2012 AZILECT Teva rasagiline mesylate 5,457,133 Feb 7, 2012 AZILECT Teva rasagiline mesylate 5,786,390 Feb 7, 2012 *Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details. The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the DrugPatentWatch database for complete details DISCLAIMER: Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice. All trademarks and applicant names are the property of their respective owners or licensors. ]]> http://www.biotechblog.com/2012/02/11/drug-patent-expirations-for-feb-7-2012/feed/ 0 http://www.biotechblog.com/2012/02/11/wind-energy-update-europes-leading-offshore-wind-supply-chain/ http://www.biotechblog.com/2012/02/11/wind-energy-update-europes-leading-offshore-wind-supply-chain/#comments Sat, 11 Feb 2012 09:08:12 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9183594.htm http://www.biotechblog.com/2012/02/11/wind-energy-update-europes-leading-offshore-wind-supply-chain/feed/ 0 http://www.biotechblog.com/2012/02/11/wind-energy-update-europes-leading-offshore-wind-supply-chain/ http://www.biotechblog.com/2012/02/11/wind-energy-update-europes-leading-offshore-wind-supply-chain/#comments Sat, 11 Feb 2012 09:08:12 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9183594.htm http://www.biotechblog.com/2012/02/11/wind-energy-update-europes-leading-offshore-wind-supply-chain/feed/ 0 http://www.biotechblog.com/2012/02/10/vergence-labs-smart-eyeglasses-display-facebook-and-google-into-the/ http://www.biotechblog.com/2012/02/10/vergence-labs-smart-eyeglasses-display-facebook-and-google-into-the/#comments Sat, 11 Feb 2012 01:23:24 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9188672.htm http://www.biotechblog.com/2012/02/10/vergence-labs-smart-eyeglasses-display-facebook-and-google-into-the/feed/ 0 http://www.biotechblog.com/2012/02/10/noble-biomaterials-raises-8-million-in-series-b-equity-financing/ http://www.biotechblog.com/2012/02/10/noble-biomaterials-raises-8-million-in-series-b-equity-financing/#comments Fri, 10 Feb 2012 10:13:45 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9180863.htm http://www.biotechblog.com/2012/02/10/noble-biomaterials-raises-8-million-in-series-b-equity-financing/feed/ 0